MDUFMA Update: FDA Tackles Performance Goals, Premarket Review Funding
This article was originally published in The Gray Sheet
Executive Summary
Year-one implementation of the Medical Device User Fee & Modernization Act was marked by both progress and challenges as FDA worked to build a foundation for meeting new performance goals and to execute some of the 2002 law's more controversial provisions
You may also be interested in...
Interview With OIVD: Reflections On New Office, Evolving Tests And Policies
FDA's Office of In Vitro Diagnostic Device Evaluation & Safety will continue to streamline its 510(k) process, develop metrics and scorecards and refine compliance strategies in 2004
United They Stand? Differing Device Platforms Share FDA Oversight Plank
Device advocacy groups credit a maturing industry presence on Capitol Hill, reflected by CEO-level participation, with achieving relevant Medicare reforms and a focus on FDA accountability
Interview With OIVD: Reflections On New Office, Evolving Tests And Policies
FDA's Office of In Vitro Diagnostic Device Evaluation & Safety will continue to streamline its 510(k) process, develop metrics and scorecards and refine compliance strategies in 2004